Nicholas Investment Partners’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
NAMA
Nicholas Investment Partners's TWST Position: Q4 2022 in Review
Nicholas Investment Partners sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 320,168 shares — an estimated $11.3M sold.
Nicholas Investment Partners first reported a position in TWST in Q1 2020 and held it in 11 quarters. The position peaked at $25.3M in Q4 2020. 199 funds tracked by Wall St. Rank hold TWST as of Q4 2022.
- Nicholas Investment Partners reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
- Nicholas Investment Partners sold 320,168 Twist Bioscience shares in Q4 2022, an estimated $11.3M.
- Nicholas Investment Partners first reported a position in Twist Bioscience in Q1 2020 and held it in 11 quarters.
- Nicholas Investment Partners's Twist Bioscience position peaked at $25.3M in Q4 2020.
- 199 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.
Based on Nicholas Investment Partners's 13F filing for Q4 2022, filed 10 Feb 2023.